AMTM
Amentum Holdings, Inc.
AMTM offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BA
The Boeing Company
BA has the edge over AMTM overall, supported by stronger fundamentals and lower modeled downside.
AMTM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Under pressure |
AMTM's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
AMTM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.6x | $22.15 | — |
| Cheap | 26x | $21.30 | -3.8% |
| Current | 27x | $22.15 | — |
| Fair | 39x | $32.14 | +45% |
| Expensive | 108x | $89.29 | +303% |
Historical ranges are pointers, not guarantees.
AMTM's PE is in its cheap range at 27x. If earnings grow as analysts expect, today's price would be 8.6x next year's earnings.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over AMTM in the historical PE scenario, which offers more potential upside but is not a forecast.
AMTM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect AMTM's earnings to grow and its profitability to improve, with its revenue holding steady.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over AMTM on the outlook, with more favorable revenue expectations.
AMTM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.58 | +211% |
| Q2 2026 | $0.83 | +$3.68 |
| Q1 2026 | $0.60 | +$3.66 |
| Q4 2025 | $0.40 | +$2.76 |
| Q3 2025 | $0.27 | +$1.96 |
| Q2 2025 | -$2.85 | -271% |
| Q1 2025 | -$3.06 | -280% |
| Q4 2024 | -$2.36 | -298% |
| Q3 2024 | -$1.69 | -349% |
AMTM has returned to profit: it earned $0.83 per share over the past year, after losing money the year before.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
AMTM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.5B | -2% |
| Q1 2026 | $3.5B | -0.4% |
| Q4 2025 | $3.2B | -5.2% |
| Q3 2025 | $3.9B | -7.5% |
| Q2 2025 | $3.6B | +66% |
| Q1 2025 | $3.5B | +145% |
| Q4 2024 | $3.4B | +151% |
| Q3 2024 | $4.2B | +189% |
AMTM's revenue fell from its 2024 peak and has held roughly level since: $3.5B last quarter, down 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 4.9% | +2 points |
| Q1 2026 | 4.3% | +1.2 points |
| Q4 2025 | 4.3% | +0.4 points |
| Q3 2025 | 3.4% | +2.8 points |
| Q2 2025 | 2.9% | -1.3 points |
| Q1 2025 | 3.1% | -3.2 points |
| Q4 2024 | 3.9% | -2.6 points |
| Q3 2024 | 0.6% | -6 points |
AMTM has the edge over BA on profitability, with a higher operating margin.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
AMTM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $135M | +35% |
| Q1 2026 | $220M | +315% |
| Q4 2025 | -$142M | -239% |
| Q3 2025 | $261M | +$378.2M |
| Q2 2025 | $100M | -58% |
| Q1 2025 | $53M | +2550% |
| Q4 2024 | $102M | +$187M |
| Q3 2024 | -$117.2M | -218% |
AMTM generated $474M in free cash flow over the past year, about three times what it generated the year before.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over AMTM on cash flow, with more consistent year-over-year improvement.
AMTM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +0.8% | +2M shares |
| 3 years | +0.7% | +1.7M shares |
AMTM has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
AMTM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 3.3x | Elevated |
| Q1 2026 | 3.5x | Elevated |
| Q4 2025 | 3.8x | Elevated |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 4.4x | High |
| Q1 2025 | 5.4x | High |
| Q4 2024 | 6.6x | High |
| Q3 2024 | 9.4x | High |
AMTM's net debt is about 3.3 years of its operating earnings (EBITDA), down from 4.4 years a year ago.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA has the edge over AMTM on leverage, with a lower net debt burden relative to earnings.
AMTM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.2 | Neutral |
| Stochastic | 54.9 | Neutral |
AMTM's weekly RSI is 51 (neutral) and its Stochastic is 55 (neutral).
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
AMTM PE vs Industrials Sector
| Metric | AMTM | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 24x | 11% above |
| PE % | 26 | 32 | 6 pts below |
AMTM is trading at 27x earnings, a 11% premium to the Industrials sector's median of 24x.
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over AMTM on valuation relative to its sector.
AMTM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.4 | 8.6% above |
| 20 week MA | $20.9 | 6% above |
| 50 week MA | $25.2 | 12% below |
| 100 week MA | $23.7 | 6.5% below |
AMTM has stronger trend alignment. AMTM is above 2 of 4 weekly averages versus BA above 0 of 5.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
AMTM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $25.7 | $20.5 | -20% |
| 2025 | $20.5 | $29.7 | +45% |
| 2026 YTD | $29.7 | $22.2 | -25% |
AMTM has finished lower in one of the last two years. It's down 25% so far in 2026.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over AMTM on returns for 2026, with the stronger performance.